Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

New melanoma drug gives 63 percent reduction in risk of death compared to dacarbazine

Dr Paul Chapman, Memorial Sloan-Kettering Cancer Center
New melanoma drug gives 63 percent reduction in risk of death compared to dacarbazine ( Dr Paul Chapman, Memorial Sloan-Kettering Cancer Center )
17 Jun 2011

Ipilimumab improves survival in metastatic melanoma

Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA
Ipilimumab improves survival in metastatic melanoma ( Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA )
17 Jun 2011

Highlights from 2011 and ASCO’s future

Prof George Sledge - Indiana University, USA
Highlights from 2011 and ASCO’s future ( Prof George Sledge - Indiana University, USA )
17 Jun 2011

ASCO 2011 highlights

Prof Gordon McVie – ecancer Managing Editor
ASCO 2011 highlights ( Prof Gordon McVie – ecancer Managing Editor )
16 Jun 2011

The future of medicine: personalised

Prof Hans Lehrach - Max Planck Institute for Molecular Genetics, Berlin, Germany
The future of medicine: personalised ( Prof Hans Lehrach - Max Planck Institute for Molecular Genetics, Berlin, Germany )
2 Jun 2011

Reducing global cancer mortality

Prof Peter Boyle - International Prevention Research Institute, Lyon, France
Reducing global cancer mortality ( Prof Peter Boyle - International Prevention Research Institute, Lyon, France )
2 Jun 2011

The Cancer Genome Atlas (TCGA)

Dr Paul Spellman - National Cancer Institute, Bethesda, USA
The Cancer Genome Atlas (TCGA) ( Dr Paul Spellman - National Cancer Institute, Bethesda, USA )
21 Apr 2011

Combination therapy targeting MEK and PI3K pathways shows anti-tumour activity

Dr Johanna Bendell - Sarah Cannon Research Institute, Nashville, USA
Combination therapy targeting MEK and PI3K pathways shows anti-tumour activity ( Dr Johanna Bendell - Sarah Cannon Research Institute, Nashville, USA )
20 Apr 2011

Ethical considerations surrounding cancer in the elderly and the pros and cons of web-based resources

Ian Banks (European Men's Health Forum), Jan Geissler (Leukamie-Online), Ellen Verschuur (Europa Donna)
Ethical considerations surrounding cancer in the elderly and the pros and cons of web-based resources ( Ian Banks (European Men's Health Forum), Jan Geissler (Leukamie-Online), Ellen Verschuur (Europa Donna) )
17 Mar 2011

Treatment of brain metastases in melanoma patients

Dr Caroline Robert - Institute Gustave Roussy, Paris, France; Prof Alexander Eggermont - Erasmus University of Rotterdam, Netherlands
Treatment of brain metastases in melanoma patients ( Dr Caroline Robert - Institute Gustave Roussy, Paris, France; Prof Alexander Eggermont - Erasmus University of Rotterdam, Netherlands )
7 Feb 2011

Sarah Cannon Research Institute research developments at ASCO 2010

Dr Howard Burris, The Sarah Cannon Research Institute, Nashville
Sarah Cannon Research Institute research developments at ASCO 2010 ( Dr Howard Burris, The Sarah Cannon Research Institute, Nashville )
4 Feb 2011

Clinical benefits and side effects of ipilimumab in melanoma patients

Prof. Giorgio Parmiani - Fondazione San Raffaele del Monte Tabor, Milan, Italy
Clinical benefits and side effects of ipilimumab in melanoma patients ( Prof. Giorgio Parmiani - Fondazione San Raffaele del Monte Tabor, Milan, Italy )
31 Jan 2011